Provider
QP24-25 Commercial Pharmacy Benefit Exclusion for Octreotide Kit, Sandostatin® Kit LAR, and Signifor® LAR injection
Program effective Date: Mar 12, 2025
Program effective Date: Mar 12, 2025
Program effective Date: Mar 12, 2025
Program effective Date: Mar 12, 2025
Program effective Date: Mar 12, 2025
Program effective Date: Jul 01, 2025